I Have HPV. Does My Partner Need to Be Tested?

Medical guidelines do not recommend HPV testing for the male partners of women diagnosed with HPV, and there is no FDA-approved HPV screening test for men used in routine clinical practice. This surprises many people, because the instinct after any sexually transmitted infection diagnosis is to get your partner checked too. But HPV is different from most STIs in ways that make standard partner testing largely uninformative. The virus is extraordinarily common, often shared between partners long before anyone knows it is there, and testing a male partner would rarely change what either person should do next.

Why There Is No Routine HPV Test for Men

HPV testing in women works because there is a well-defined anatomical target: the cervix. Clinicians can swab the cervical transformation zone, where HPV tends to cause the cellular changes that lead to cancer, and get a reliable result. Men have no equivalent single site. The virus can live on penile skin, the scrotum, the perianal area, the urethra, or the oral cavity, and sampling all of those locations still might miss an infection. There is no standardized collection method, no validated cutoff for what constitutes a clinically meaningful result, and no approved test kit designed for male genital HPV screening.¹

Even if a reliable test existed, the clinical usefulness would be limited. There is no treatment for HPV itself in men or women. The virus is managed by monitoring for the problems it can cause, like abnormal cervical cells or genital warts, not by trying to eradicate the virus from the body. A positive male HPV test would not lead to any specific medical intervention, and a negative test would not mean he was truly free of the virus, since sampling errors are common on keratinized skin surfaces. This is why professional bodies like the CDC and most international guidelines skip male HPV testing entirely.

Your Partner Almost Certainly Already Carries the Virus

One of the strongest reasons testing a male partner adds little value is that couples in established sexual relationships tend to share HPV types already. Studies that have tested both partners find remarkably high overlap. Research measuring HPV concordance between heterosexual couples found that shared detection of at least one HPV type ranged from 64% to 95%, with the highest concordance detected within 24 hours after intercourse.² When researchers looked specifically at whether both partners carried the same HPV type, concordance was about 42% in couples where at least one partner tested positive.³ A Brazilian study found type-specific concordance in roughly 57% of couples, and among those concordant couples, about 85% of the men carried the same high-risk type as their female partner.⁴

The practical implication is straightforward: by the time you receive an HPV diagnosis, you and your long-term partner have almost certainly been exchanging the virus for months or years. Testing him would most likely confirm what is already the default assumption. And even if the test came back negative, it could simply mean the sample missed the virus rather than that he never had it.

HPV Can Linger Below the Radar for Years

HPV does not behave like a bacterial infection that arrives, causes symptoms, and either gets treated or gets worse. Most HPV infections produce no symptoms at all, and the immune system suppresses or clears the detectable virus within one to two years. But “clearance” in HPV research usually means that viral DNA has dropped below the level a test can pick up, not necessarily that every trace of the virus is gone. Research into HPV latency suggests the virus can persist in a dormant state, kept in check by the immune system, and occasionally become detectable again without any new sexual exposure.⁵

This has a real impact on how couples think about blame and timing. An HPV diagnosis today does not mean the infection was acquired recently. It could have been picked up from a partner years ago and only now become detectable, or it could have been suppressed and then reactivated. There is simply no way to determine when or from whom you got the virus. This is one of the reasons doctors emphasize that an HPV-positive result is not evidence of infidelity. The virus’s ability to hide makes questions about origin essentially unanswerable.

What Your Partner Should Actually Do

Just because there is no HPV test for men does not mean your partner should do nothing. The appropriate response depends on who your partner is and what risks apply to them.

If your partner is a woman, she should stay current with her own cervical screening. HPV co-testing or primary HPV testing is now part of cervical cancer screening guidelines in many countries. Her own screening will catch any HPV-related cervical changes far more reliably than trying to trace the virus from your result to hers.

If your partner is a man, the most actionable step is awareness. He should know the signs of HPV-related problems: new or changing genital warts, any unusual lumps or sores on the penis or around the anus, persistent sore throat or hoarseness that does not resolve. Men have no routine screening equivalent to a Pap test, so self-monitoring and prompt medical attention for anything unusual is the primary line of defense.

Vaccination is relevant for both partners if they are within the recommended age range (up to 26, and in some cases up to 45 after discussion with a doctor). Even if someone already has one HPV type, the vaccine protects against others they have not encountered yet. Getting vaccinated after a partner’s diagnosis is not pointless; it just will not help with the type already present.

Condoms Help, but They Do Not Solve the Problem

Condoms are worth using, but they offer less protection against HPV than against most other STIs. HPV lives on skin surfaces that a condom does not cover, including the base of the penis, the scrotum, the vulva, and the perianal area. That said, consistent condom use does reduce the risk meaningfully. A study of young women whose partners used condoms every time found that genital HPV infection rates dropped by about 70% compared to women whose partners almost never used condoms.⁶

That reduction is significant, even though it is not the near-total protection condoms provide against infections like HIV or gonorrhea. For couples where one partner has a known high-risk HPV type, consistent condom use makes sense as one layer of risk reduction, especially if the relationship is newer and there is a realistic chance the partner has not yet been exposed. In long-established relationships where the virus has likely already been shared, the decision about condom use is more nuanced and is worth discussing with a clinician.

The Emotional Weight of an HPV Diagnosis

The medical reality of HPV, that it is almost universal, rarely dangerous, and usually transient, does not always match the emotional experience of getting diagnosed. Research consistently finds that testing positive for HPV triggers real distress, much of it tied to the sexually transmitted label. Women in qualitative studies described feelings of stigma, anxiety, and stress after a positive result, along with significant worry about how the diagnosis would affect their sexual relationships.⁷

Disclosure is often the hardest part. Many women do tell their partners, but how they frame the conversation and how the partner reacts varies widely. The factors that shaped the emotional fallout included how well the woman understood HPV biology, whether she worried about transmitting it to someone else, and whether the infection persisted on repeat testing.⁸ Partners who understood how common HPV is and how unreliable timing-of-infection estimates are tended to react with less alarm. In other words, education is the best tool for managing the relational side of an HPV diagnosis. The conversation goes better when both people understand that HPV is not a marker of risky behavior; it is a near-inevitable consequence of being sexually active.

Does Your Partner Face a Higher Cancer Risk Because of Your Diagnosis?

This is one of the most common fears, and the reassuring answer is that the absolute risk is very small. A systematic review examining whether spouses of people with HPV-related cancers had a higher chance of developing their own HPV-related cancer found that while a slight statistical increase existed, the absolute risk increase across the studies was on the order of 1% to 3%.⁹ That small increase showed up primarily in very specific situations, like husbands of women with cervical cancer having a slightly elevated risk of tonsil or tongue cancer. For the vast majority of couples dealing with a routine HPV-positive screening result (as opposed to an actual HPV-related cancer), the cancer risk to the partner is not elevated in any clinically meaningful way.

The distinction matters because an HPV-positive cervical screening result and an HPV-related cancer are very different situations. Most high-risk HPV infections never progress to cancer. The screening exists precisely to catch the rare cases that do progress, usually over a decade or more, so they can be treated before they become dangerous. Your partner’s worry should scale to the actual finding: a positive HPV screen with normal cytology is a common result that usually resolves on its own and poses no special threat to anyone.

When Partner Screening Does Matter

There are populations where HPV screening of partners, or at least targeted anatomical screening, becomes more relevant. Men who have sex with men face elevated rates of anal HPV infection and anal cancer. Anal HPV screening using cytology and genotyping is increasingly offered to this group, particularly those living with HIV, who carry a disproportionately high burden of persistent high-risk HPV.¹⁰ In these populations, HPV types 16 and 18 remain the dominant drivers of high-grade disease, but non-16/18 high-risk types are also common and clinically relevant.¹¹

For men who have sex with men, especially those who are HIV-positive, asking about anal cancer screening is a reasonable step after a partner’s HPV diagnosis. This is not routine male HPV testing in the sense most people imagine; it is site-specific cancer screening similar in concept to cervical screening for women. The evidence supports that high-risk HPV-positive men in this group have a higher prevalence of precancerous anal lesions compared to women with the same HPV status.¹² If your partner falls into a high-risk category, a conversation with his doctor about anal screening is warranted regardless of your individual diagnosis.

Oral HPV and What It Means for Partners

Oropharyngeal cancers caused by HPV have been rising for years, and this understandably makes people nervous about oral sex. But the transmission dynamics for oral HPV are different from genital HPV. A review of the evidence found that oral HPV-related cancer survivors and their partners do not show increased risk of oral HPV infection during sexual contact, and that transmission to the oral cavity through routes like autoinoculation with fingers or deep kissing appears to be of limited importance.¹³

This does not mean oral HPV transmission never happens, but the oral cavity seems to be a less hospitable environment for the virus to establish a persistent infection. The vast majority of oral HPV infections are transient. For couples concerned about oropharyngeal cancer risk, the most useful information is that the absolute risk remains low even among partners of people with HPV-related cancers, as noted above. There is currently no recommended oral HPV screening test for the general population.

HPV Can Spread Without Sex

One detail that often surprises people is that HPV is not exclusively a sexually transmitted infection. The virus has been detected on surfaces, medical instruments (even after standard disinfection), and across non-genital body sites in healthy adults. HPV DNA has been found on skin in over 60% of healthy adults tested, in the oral cavity in about 30%, and even in breast milk.¹⁴ Non-sexual transmission routes include fomites (contaminated objects), finger-to-genital contact, and skin-to-skin contact that is not sexual in nature. Standard hygiene measures have not been shown to reliably prevent HPV spread on contaminated surfaces.¹⁵

This does not mean you should worry about catching HPV from a doorknob. Sexual contact remains overwhelmingly the primary route for genital HPV types. But the existence of non-sexual transmission reinforces an important point: HPV is so pervasive that assigning blame or tracing the exact source of an infection is a fool’s errand. The virus is part of the human viral landscape in a way that few other pathogens are. Knowing this can help take some of the sting out of a diagnosis and defuse the accusation dynamic that sometimes surfaces in relationships.

Self-Sampling as an Alternative for Women Partners

If your partner is a woman who has been avoiding cervical screening because of discomfort, inconvenience, or lack of access, self-sampling kits are an increasingly available option. Vaginal self-collected samples perform nearly as well as clinician-collected cervical swabs for detecting HPV, with sensitivity around 96% for HPV detection and matching sensitivity for identifying high-grade cervical lesions.¹⁶ Urine-based testing is also under study, though it currently has somewhat lower sensitivity. Several countries now offer or are piloting mail-in self-sampling programs, and some direct-to-consumer options are available depending on where you live.

Self-sampling does not replace the full cervical screening pathway: a positive HPV result from a self-collected sample still needs follow-up with a clinician for triage, which usually means a Pap test or colposcopy. But as a way to get a partner into the screening pipeline who might otherwise never go, it is a practical and well-validated option. If your HPV diagnosis prompts your female partner to check her own screening status, that alone may be the most useful outcome of the conversation.